Cargando…

Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients

Introduction: ESCRT is a molecular machine involved in various important physiological processes, such as the formation of multivesicular bodies, cellular autophagy, and cellular membrane repair. CHMP7 is a regulatory subunit of ESCRT-III and is necessary for the proper functioning of ESCRT. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu, Wang, Shu, Liang, Feng, Wang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499328/ https://www.ncbi.nlm.nih.gov/pubmed/37711849 http://dx.doi.org/10.3389/fcell.2023.1211843

Ejemplares similares

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

CDK1 controls CHMP7-dependent nuclear envelope reformation
por: Gatta, Alberto T, et al.
Publicado: (2021)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
por: Li, Xiushen, et al.
Publicado: (2021)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021)

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022)

Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer
por: Song, Xiaodong, et al.
Publicado: (2022)

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients
por: Yue, Taohua, et al.
Publicado: (2022)

The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
por: Yang, Ronghua, et al.
Publicado: (2021)

Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
por: Wang, Yao, et al.
Publicado: (2021)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Transcriptomic and Metabolomic Profiling in Helicobacter pylori–Induced Gastric Cancer Identified Prognosis- and Immunotherapy-Relevant Gene Signatures
por: Liu, Duanrui, et al.
Publicado: (2021)

Siglec-15 Is an Immune Suppressor and Potential Target for Immunotherapy in the Pre-Metastatic Lymph Node of Colorectal Cancer
por: Du, Hang, et al.
Publicado: (2021)

The Expression Pattern of Hypoxia-Related Genes Predicts the Prognosis and Mediates Drug Resistance in Colorectal Cancer
por: Yuan, Ye, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
por: Zhuo, Zewei, et al.
Publicado: (2022)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
por: Chen, Meng-Yu, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Liu, Yu, et al.
Publicado: (2022)

Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
por: Luo, Zhiwen, et al.
Publicado: (2021)

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Yi, Yonglin, et al.
Publicado: (2022)

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
por: Gao, Ze, et al.
Publicado: (2021)

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs
por: Zhi, Yuan, et al.
Publicado: (2021)

The promising roles of macrophages in geriatric hip fracture
por: Lu, Yi-ning, et al.
Publicado: (2022)

Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma
por: Sun, Yifang, et al.
Publicado: (2021)

Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics
por: Liu, Yang, et al.
Publicado: (2022)

Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Aye, Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnju2e5fcp3l1gorckiqeilo7v